Author

Gregory M Tiao

Every paper listing this name carries an ORCID.

Identified by ORCID

Gregory M TiaoiD1 paper · Cincinnati Children's Hospital Medical Center

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Organism:human· 2 Approach:statistical model· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1

Frequent Co-Authors

Alexander Gerhard MiethkeiD· 1 shared Alexander J. BondociD· 1 shared Amy E. TayloriD· 1 shared Anas BerniehiD· 1 shared Andrew BadachhapeiD· 1 shared Annika Yang vom HofeiD· 1 shared Brian T HickneriD· 1 shared Bruce J. AronowiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Alexander Gerhard MiethkeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Oncogenic Role of Aberrant EZH2 in Hepatoblastoma

Kathryn Glaser, Lara E. Berklite, Brian T Hickner, Priyanka Rao, Roma H. Patel, Andrew Badachhape, Somak Roy, Emily J. Schepers, Nikolai A. Timchenko, James I. Geller, Sarangarajan Ranganathan, Gregory M. Tiao, Bruce J. Aronow, Takanori Takebe, Sarah E. Woodfield, , Alexander J. Bondoc

This study identifies EZH2 as an oncogenic driver in hepatoblastoma, showing its role in promoting tumor progression through epigenetic silencing and noncanonical signaling, and highlights its potential as a therapeutic target.

bioRxiv · Jul 30, 2025 · PreprintCancer Biology

Cholestasis alters polarization and suppressor function of hepatic regulatory T cells.

Ramesh Kudira, Z. F. Yang, Immaculeta Osuji, Rebekah A. Karns, Priya Bariya, Liva Pfuhler, Mary M. Mullen, Amy E. Taylor, Hongjian Ji, Celine Silva Lages, Annika Yang vom Hofe, Tiffany Shi, Srikar Pasula, Joseph A. Wayman, Anas Bernieh, , Alexander Gerhard Miethke

This study shows cholestasis shifts hepatic Tregs to a Th17 phenotype and impairs their suppressor function, with bile acid levels influencing Treg activity and liver injury.

bioRxiv · May 17, 2024 · PreprintImmunology